Oral Premalignant Lesions
📧 Sign up to get email alerts when something new happens for Oral Premalignant Lesions.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions [Phase 2]
A Phase II randomized, placebo-controlled trial is being conducted to evaluate intralesional nivolumab for high-risk oral premalignant lesio…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Real-time Molecular Diagnosis of Oral Precancer
A ClinicalTrials.gov entry describes a study on real-time molecular diagnosis of oral precancer, with the status NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions [Phase 2]
Phase 2 trial update of an immune checkpoint inhibitor for high-risk oral premalignant lesions (oral premalignant lesions).
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization [Phase 2]
A Phase 2 trial update on sintilimab aimed at preventing cancerization in high-risk oral premalignant lesions.
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: 8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions
Clinical trial update from Fayoum University indicates the study evaluating 8-Hydroxy-2-Deoxyguanosine and total antioxidant capacity in ora…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions
A completed clinical trial evaluating salivary and serum levels of chemerin and MMP-9 in oral premalignant lesions and oral cancer.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Wild Type p53 Adenovirus for Oral Premalignancies [Phase 1]
A Phase 1 trial evaluating a wild-type p53 adenovirus for oral premalignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-09-29Clinical Trial Update: Chemoprevention of Oral Premalignant Lesions [Phase 2]
Pfizer-sponsored Phase 2 trial evaluating chemoprevention of oral premalignant lesions has completed.